BIOGEN INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 227.2 USD | -1.21% |
|
+2.28% | -12.45% |
| May. 16 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| May. 16 | Sector Update: Health Care Stocks Ease Thursday Afternoon | MT |
ETFs positioned on Biogen Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 34 M€ | +12.61% | - | |
| 0.09% | 322 M€ | +13.88% | - | |
| 0.09% | 29 M€ | -.--% | - | |
| 0.09% | 1 M€ | -.--% | ||
| 0.08% | 1,006 M€ | -.--% | - | |
| 0.08% | 414 M€ | +13.56% | - | |
| 0.08% | 2,517 M€ | +13.25% | - | |
| 0.08% | 14 M€ | +16.19% | - | |
| 0.07% | 0 M€ | 0.00% | - | |
| 0.07% | 23 M€ | -.--% | - | |
| 0.07% | 786 M€ | -.--% | ||
| 0.07% | 607 M€ | +0.05% | - | |
| 0.07% | 1,166 M€ | +0.26% | - | |
| 0.07% | 9 M€ | +10.60% | ||
| 0.07% | 571 M€ | +8.43% | - | |
| 0.07% | 9 M€ | +10.70% | - | |
| 0.06% | 283 M€ | +20.56% | ||
| 0.06% | 34 M€ | +9.38% | - | |
| 0.06% | 206 M€ | -.--% | ||
| 0.06% | 391 M€ | +9.28% | - | |
| 0.06% | 284 M€ | -.--% | ||
| 0.05% | 306 M€ | +6.49% | - | |
| 0.05% | 39 M€ | +6.61% | - | |
| 0.05% | 45 M€ | 0.00% | - | |
| 0.04% | 756 M€ | +0.87% | - | |
| 0.04% | 2 M€ | +3.16% | - |
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
Pharmaceuticals
Calendar
2024-06-20
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
230
USD
Average target price
285.9
USD
Spread / Average Target
+24.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.45% | 33.49B | |
| -2.32% | 92.59B | |
| +3.16% | 41.43B | |
| -20.86% | 14.62B | |
| -9.62% | 12.77B | |
| -12.25% | 11.58B | |
| -44.00% | 11.35B | |
| +4.42% | 8.97B | |
| -6.32% | 8.3B | |
| -7.85% | 7.02B |
- Stock Market
- Equities
- BIIB Stock
- Funds and ETFs Biogen Inc.